Novo completed the acquisition of Medical Knowledge Group from Court Square Capital and Aisling Capital for $1.1bn.

Novo, a life science investor with a focus on creating long-term value, completed the acquisition of Medical Knowledge Group, a New York based, independent analytics-driven and technology-enabled multi-channel marketing solutions provider, from private equity firms Court Square Capital and Aisling Capital for $1.1bn. "With the remarkable growth trajectory of the biopharmaceutical services industry, largely driven by more complex therapeutics reaching the market and an increased global demand for omnichannel communications targeting healthcare providers, MKG has positioned itself in a very attractive space which fits well with the strategic objectives of the Principal Investment arm at Novo Holdings. I very much look forward to joining the team and becoming part of the continuous growth of MKG," Abhijeet Lele, Novo Senior Partner.